Table 2.
Risk factors of ILD in patients with idiopathic inflammatory myopathies.
| Covariate | Adjusted OR (95% CI) | p value |
|---|---|---|
| Age at diagnosis | 1.029 (1.010–1.047) | 0.002 |
| Female | 1.237 (0.757–2.021) | 0.396 |
| Gottron’s rash | 1.138 (0.693–1.867) | 0.610 |
| Arthralgia | 1.954 (1.144–3.339) | 0.014 |
| Mechanic’s hand | 4.365 (0.946–20.144) | 0.059 |
| Dysphagia | 0.717 (0.406–1.268) | 0.253 |
| Tumor | 0.615 (0.280–1.351) | 0.226 |
| Lung infection | 1.803 (1.068–3.046) | 0.027 |
| Tuberculosis | 0.512 (0.229–1.143) | 0.102 |
| Respiratory failure | 2.379 (0.716–7.910) | 0.157 |
| Hemoglobin | 1.016 (1.002–1.031) | 0.022 |
| Ferritin | 1.000 (1.000–1.001) | 0.799 |
| CAR | 1.554 (1.091–2.212) | 0.014 |
| NLR | 0.980 (0.919–1.046) | 0.545 |
| PLR | 1.001 (0.999–1.002) | 0.540 |
| Anti-Ro52 antibody | 1.441 (0.931–2.231) | 0.101 |
| Anti-ARS antibody | 2.830 (1.673–4.787) | < 0.001 |
| Anti-MDA5 antibody | 7.472 (3.914–14.263) | < 0.001 |
CAR, the C-reactive protein to Albumin ratio; NLR, Neutrophil-to-lymphocyte ratio; PLR, platelet-lymphocyte ratio; ARS, aminoacyl-tRNA synthetase.